{"id":9698,"date":"2021-04-19T14:58:32","date_gmt":"2021-04-19T12:58:32","guid":{"rendered":"https:\/\/ggba.swiss\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/"},"modified":"2023-07-04T13:43:35","modified_gmt":"2023-07-04T11:43:35","slug":"start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/","title":{"rendered":"Start-up de diagnostics de propension \u00e0 la calcification, Calciscon l\u00e8ve CHF 2,5 millions"},"content":{"rendered":"<p>Fond\u00e9e en 2013 \u00e0 la suite de perc\u00e9es dans le domaine de la m\u00e9decine r\u00e9nale par Andreas Pasch qui a cherch\u00e9 \u00e0 savoir pourquoi les vaisseaux sanguins des patients atteints de maladies r\u00e9nales se calcifient rapidement, la start-up <a href=\"https:\/\/calciscon.com\/\" target=\"_blank\" rel=\"noopener\">Calciscon<\/a> a mis au point le test de propension \u00e0 la calcification T50 (test T50), le premier test officiel permettant d&rsquo;\u00e9valuer la vitesse de la calcification dans le corps.<\/p>\n<p>Le <a href=\"https:\/\/calciscon.com\/t50_explained\" target=\"_blank\" rel=\"noopener\">test sanguin T50<\/a>, qui b\u00e9n\u00e9ficie du marquage CE, permet d&rsquo;identifier les patients pr\u00e9sentant un risque cardiovasculaire \u00e9lev\u00e9 et permet d&rsquo;orienter les th\u00e9rapies pour ralentir la progression de la maladie. Ces informations aident les m\u00e9decins \u00e0 mieux adapter les traitements des patients atteints de maladies r\u00e9nales.<\/p>\n<p>De multiples \u00e9tudes indiquent que les th\u00e9rapies guid\u00e9es par le T50 ralentissent la propension \u00e0 la calcification, et pourraient ainsi consid\u00e9rablement r\u00e9duire les complications cardiovasculaires, qui restent la cause la plus fr\u00e9quente de morbidit\u00e9 et de mortalit\u00e9 chez les patients atteints de maladies r\u00e9nales.<\/p>\n<p>\u00ab\u00a0Le test T50 offre une occasion sans pr\u00e9c\u00e9dent de r\u00e9duire les dommages et les co\u00fbts de sant\u00e9 consid\u00e9rables associ\u00e9s aux complications cardiovasculaires\u00a0\u00bb, explique Andreas Pasch, inventeur du test T50 et fondateur de Calciscon.<\/p>\n<p>La soci\u00e9t\u00e9 a r\u00e9cemment cl\u00f4tur\u00e9 un tour de financement de s\u00e9rie A de CHF 2,5 millions, qui lui permettra d&rsquo;acc\u00e9l\u00e9rer l&rsquo;introduction de son test T50 en utilisation clinique courante en Europe, et de pr\u00e9parer un lancement aux \u00c9tats-Unis. Ce tour de table a \u00e9t\u00e9 r\u00e9alis\u00e9 aupr\u00e8s d&rsquo;un groupe d&rsquo;investisseurs dirig\u00e9 par la soci\u00e9t\u00e9 suisse <a href=\"http:\/\/www.yellowstoneholding.ch\/\" target=\"_blank\" rel=\"noopener\">Yellowstone Holding<\/a>.<\/p>\n<p>Bas\u00e9e \u00e0 Nidau dans le canton de Berne, Calciscon a jusqu&rsquo;\u00e0 pr\u00e9sent lev\u00e9 un total de CHF 5 millions en capitaux propres cumul\u00e9s.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La start-up medtech bernoise Calciscon, qui a d\u00e9velopp\u00e9 le premier et unique test sanguin diagnostique pour l&rsquo;\u00e9valuation de la formation de particules de phosphate cristallin dans le sang, a annonc\u00e9 la cl\u00f4ture d&rsquo;un tour de financement de s\u00e9rie A d&rsquo;un montant de CHF 2,5 millions.<\/p>\n","protected":false},"author":3,"featured_media":9699,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1041,1060,1068],"class_list":["post-9698","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-financing-fr","tag-medtech-fr","tag-personalized-medicine-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Start-up de diagnostics de propension \u00e0 la calcification, Calciscon l\u00e8ve CHF 2,5 millions - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Start-up de diagnostics de propension \u00e0 la calcification, Calciscon l\u00e8ve CHF 2,5 millions - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"La start-up medtech bernoise Calciscon, qui a d\u00e9velopp\u00e9 le premier et unique test sanguin diagnostique pour l&#039;\u00e9valuation de la formation de particules de phosphate cristallin dans le sang, a annonc\u00e9 la cl\u00f4ture d&#039;un tour de financement de s\u00e9rie A d&#039;un montant de CHF 2,5 millions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-19T12:58:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:43:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Calciscon_630x380-2.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"Start-up de diagnostics de propension \u00e0 la calcification, Calciscon l\u00e8ve CHF 2,5 millions\",\"datePublished\":\"2021-04-19T12:58:32+00:00\",\"dateModified\":\"2023-07-04T11:43:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/\"},\"wordCount\":315,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Calciscon_630x380-2.jpeg\",\"keywords\":[\"Financing\",\"Medtech\",\"Personalized Medicine\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/\",\"name\":\"Start-up de diagnostics de propension \u00e0 la calcification, Calciscon l\u00e8ve CHF 2,5 millions - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Calciscon_630x380-2.jpeg\",\"datePublished\":\"2021-04-19T12:58:32+00:00\",\"dateModified\":\"2023-07-04T11:43:35+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Calciscon_630x380-2.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Calciscon_630x380-2.jpeg\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Start-up de diagnostics de propension \u00e0 la calcification, Calciscon l\u00e8ve CHF 2,5 millions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Start-up de diagnostics de propension \u00e0 la calcification, Calciscon l\u00e8ve CHF 2,5 millions - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/","og_locale":"fr_FR","og_type":"article","og_title":"Start-up de diagnostics de propension \u00e0 la calcification, Calciscon l\u00e8ve CHF 2,5 millions - Greater Geneva Bern area","og_description":"La start-up medtech bernoise Calciscon, qui a d\u00e9velopp\u00e9 le premier et unique test sanguin diagnostique pour l'\u00e9valuation de la formation de particules de phosphate cristallin dans le sang, a annonc\u00e9 la cl\u00f4ture d'un tour de financement de s\u00e9rie A d'un montant de CHF 2,5 millions.","og_url":"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2021-04-19T12:58:32+00:00","article_modified_time":"2023-07-04T11:43:35+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Calciscon_630x380-2.jpeg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"mathieu","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"Start-up de diagnostics de propension \u00e0 la calcification, Calciscon l\u00e8ve CHF 2,5 millions","datePublished":"2021-04-19T12:58:32+00:00","dateModified":"2023-07-04T11:43:35+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/"},"wordCount":315,"image":{"@id":"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Calciscon_630x380-2.jpeg","keywords":["Financing","Medtech","Personalized Medicine"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/","url":"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/","name":"Start-up de diagnostics de propension \u00e0 la calcification, Calciscon l\u00e8ve CHF 2,5 millions - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Calciscon_630x380-2.jpeg","datePublished":"2021-04-19T12:58:32+00:00","dateModified":"2023-07-04T11:43:35+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Calciscon_630x380-2.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Calciscon_630x380-2.jpeg","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/start-up-de-diagnostics-de-propension-a-calcification-calciscon-leve-chf-2-5-millions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Start-up de diagnostics de propension \u00e0 la calcification, Calciscon l\u00e8ve CHF 2,5 millions"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/fr\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=9698"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9698\/revisions"}],"predecessor-version":[{"id":17913,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9698\/revisions\/17913"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/9699"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=9698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=9698"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=9698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}